BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

Not Applicable

Completed

Conditions: Hyperglycemia
Insulin Resistance

First Posted Date: 1999-10-19

Last Posted Date: 2015-03-25

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 18

Registration Number: NCT00004419

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy